Endra

StarFish Contribution

Thermo-Acoustic Enhanced UltraSound® (TAEUS®) combines radio frequency and ultrasound waves to measure fat in the liver in a groundbreaking way. In November 2017, ENDRA Life Sciences engaged StarFish Medical to help convert a benchtop prototype into a
commercial medical device to allow fatty liver disease progression to be monitored. StarFish support includes concepts, prototypes, production units, and regulatory clearance assistance in the USA and EU.

$100M Valuation

Endra’s Mar 05, 2021 8-K filing indicates a $125.84M CAD market capitalization.

Endra TAEUS handheld ultrasound probe used for thermo-acoustic liver assessment

Headshots of Jonathon Behr and Michael Thornton, co-founders of Endra Life Sciences

Jonathon Behr & Michael Thornton
Co-Founders

Endra TAEUS FLIP cart-based system shown with display and probe holder

Next Generation TAEUS FLIP System

Endra and StarFish engineers reviewing a TAEUS prototype in the lab

Endra and StarFish reviewing TAEUS prototype.